MicroRNA-137 promotes apoptosis in ovarian cancer cells via the regulation of XIAP

British Journal of Cancer

Volumn 116, Issue 1, 2017, Pages 66-76

  Li, Xiaodi ^a   Chen, Wei ^b   Zeng, Wenshu ^a   Wan, Chunling ^c   Duan, Shiwei ^d   Jiang, Songshan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d NINGBO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING METABOLISM; CISPLATIN; GENOMIC DNA; MICRORNA; MICRORNA 137; MICRORNA 137 INHIBITOR; MICRORNA 137 MIMIC; RENILLA LUCIFERIN 2 MONOOXYGENASE; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; 3' UNTRANSLATED REGION; MIRN137 MICRORNA, HUMAN; XIAP PROTEIN, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; CRISPR CAS SYSTEM; EXPRESSION VECTOR; FEMALE; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENOME; GENOME EDITING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; OVARIAN CANCER CELL LINE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN RNA BINDING; REPORTER GENE; TUNEL ASSAY; UPREGULATION; DRUG RESISTANCE; GENETICS; HEK293 CELL LINE; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; APOPTOSIS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84996968391     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.379     Document Type: Article

References (57)

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2): 281-297
2. Berthelet J, Dubrez L (2013) Regulation of apoptosis by inhibitors of apoptosis (IAPs). Cells 2(1): 163-187
3. Bier A, Giladi N, Kronfeld N, Lee HK, Cazacu S, Finniss S, Xiang C, Poisson L, deCarvalho AC, Slavin S, Jacoby E, Yalon M, Toren A, Mikkelsen T, Brodie C (2013) MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. Oncotarget 4(5): 665-676
4. Borley J, Brown R (2015) Epigenetic mechanisms and therapeutic targets of chemotherapy resistance in epithelial ovarian cancer. Ann Med 47: 1-11
5. Chan DW, Liu VW, To RM, Chiu PM, Lee WY, Yao KM, Cheung AN, Ngan HY (2009) Overexpression of FOXG1 contributes to TGF-beta resistance through inhibition of p21WAF1/CIP1 expression in ovarian cancer. Br J Cancer 101(8): 1433-1443
6. Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, Li YH, Kang TB, Xu RH (2013) Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis 34(4): 803-811
7. Cho SW, Kim S, Kim JM, Kim JS (2013) Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat Biotechnol 31(3): 230-232
8. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121): 819-823
9. Cui Y, Han J, Xiao Z, Chen T, Wang B, Chen B, Liu S, Han S, Fang Y, Wei J, Wang X, Ma X, Dai J (2016) The miR-20-Rest-Wnt signaling axis regulates neural progenitor cell differentiation. Sci Rep 6: 23300
10. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, ShihIeM, Zhang Y, Wood 3rdW, Becker KG, Morin PJ (2008) MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PloS one 3(6): e2436
11. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471(7340): 602-607
12. Eckelman BP, Salvesen GS, Scott FL (2006) Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep 7(10): 988-994
13. Fernandez S, RisolinoM, Mandia N, Talotta F, Soini Y, IncoronatoM, Condorelli G, Banfi S, Verde P (2015) miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene 34(25): 3240-3250
14. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19(1): 92-105
15. Guo J, Xia B, Meng F, Lou G (2013) miR-137 suppresses cell growth in ovarian cancer by targeting AEG-1. Biochem Biophys Res Commun 441(2): 357-363
16. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5(7): 522-531
17. Holcik M, Yeh C, Korneluk RG, Chow T (2000) Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 19(36): 4174-4177
18. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, Croce CM (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67(18): 8699-8707
19. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human microRNA targets. PLoS Biol 2(11): e363
20. Kang HG, Lee SJ, Chae MH, Lee WK, Cha SI, Kim CH, Kam S, Park RW, Kim IS, Kim DS, Kim YC, Jung TH, Park JY (2008) Identification of polymorphisms in the XIAP gene and analysis of association with lung cancer risk in a Korean population. Cancer Genet Cytogenet 180(1): 6-13
21. Kleinberg L, Florenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B (2007) Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma. Cancer 109(2): 228-238
22. Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera Mdel C, Yusa K (2014) Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol 32(3): 267-273
23. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (2005) Combinatorial microRNA target predictions. Nat Genet 37(5): 495-500
24. Kurzeder C, Sauer G, Deissler H (2006) Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy. Curr Cancer Drug Targets 6(3): 207-227
25. Lencz T, Guha S, Liu C, Rosenfeld J, Mukherjee S, DeRosse P, John M, Cheng L, Zhang C, Badner JA, Ikeda M, Iwata N, Cichon S, Rietschel M, Nothen MM, Cheng AT, Hodgkinson C, Yuan Q, Kane JM, Lee AT, Pisante A, Gregersen PK, Pe'er I, Malhotra AK, Goldman D, Darvasi A (2013) Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. Nat Commun 4: 2739
26. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115(7): 787-798
27. Li J, Sasaki H, Sheng YL, Schneiderman D, Xiao CW, Kotsuji F, Tsang BK (2000) Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant? Biol Signals Recept 9(2): 122-130
28. Li SD, Zhang JR, Wang YQ, Wan XP (2010) The role of microRNAs in ovarian cancer initiation and progression. J Cell Mol Med 14(9): 2240-2249
29. Li T, Li D, Sha J, Sun P, Huang Y (2009) MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun 383(3): 280-285
30. Li X, Liu X, Xu W, Zhou P, Gao P, Jiang S, Lobie PE, Zhu T (2013) c-MYCregulated miR-23a/24-2/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2. J Biol Chem 288(25): 18121-18133
31. Lopes RB, Gangeswaran R, McNeish IA, Wang Y, Lemoine NR (2007) Expression of the IAP protein family is dysregulated in pancreatic cancer cells and is important for resistance to chemotherapy. Int J Cancer 120(11): 2344-2352
32. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U (2004) Nuclear export of microRNA precursors. Science 303(5654): 95-98
33. Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339(6121): 823-826
34. McGrath LM, Cornelis MC, Lee PH, Robinson EB, Duncan LE, Barnett JH, Huang J, Gerber G, Sklar P, Sullivan P, Perlis RH, Smoller JW (2013) Genetic predictors of risk and resilience in psychiatric disorders: a crossdisorder genome-wide association study of functional impairment in major depressive disorder, bipolar disorder, and schizophrenia. Am J Med Genet B 162(8): 779-788
35. McManus DC, Lefebvre CA, Cherton-Horvat G, St-Jean M, Kandimalla ER, Agrawal S, Morris SJ, Durkin JP, Lacasse EC (2004) Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene 23(49): 8105-8117
36. Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15(5): 563-568
37. Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG, Olokpa E, Itamochi H, Ueno NT, Hawkins SM, Anderson ML, Matzuk MM (2010) A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 24(2): 447-463
38. Potkin SG, Turner JA, Guffanti G, Lakatos A, Fallon JH, Nguyen DD, Mathalon D, Ford J, Lauriello J, Macciardi F. (2009) A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr Bull 35(1): 96-108
39. Rajewsky N (2006) microRNA target predictions in animals. Nat Genet 38(Suppl): S8-S13
40. Sapi E, Alvero AB, Chen W, O'Malley D, Hao XY, Dwipoyono B, Garg M, Kamsteeg M, Rutherford T, Mor G (2004) Resistance of ovarian carcinoma cells to docetaxel is XIAP dependent and reversible by phenoxodiol. Oncol Res 14(1112): 567-578
41. Sapranauskas R, Gasiunas G, Fremaux C, Barrangou R, Horvath P, Siksnys V (2011) The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res 39(21): 9275-9282
42. Sasaki H, Sheng Y, Kotsuji F, Tsang BK (2000) Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 60(20): 5659-5666
43. Shibata H, Yamamoto K, Sun Z, Oka A, Inoko H, Arinami T, Inada T, Ujike H, Itokawa M, Tochigi M, Watanabe Y, Someya T, Kunugi H, Suzuki T, Iwata N, Ozaki N, Fukumaki Y (2013) Genome-wide association study of schizophrenia using microsatellite markers in the Japanese population. Psychiatr Genet 23(3): 117-123
44. Takwi AA, Wang YM, Wu J, Michaelis M, Cinatl J, Chen T (2014) miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells. Oncogene 33(28): 3717-3729
45. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, Reed JC (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6(5): 1796-1803
46. Ulybina YM, Kuligina ES, Mitiushkina NV, Sherina NY, Baholdin DV, Voskresenskiy DA, Polyakov IS, Togo AV, Semiglazov VF, Imyanitov EN (2011) Distribution of coding apoptotic gene polymorphisms in women with extreme phenotypes of breast cancer predisposition and tolerance. Tumori 97(2): 248-251
47. van Jaarsveld MT, Helleman J, Boersma AW, van Kuijk PF, van Ijcken WF, Despierre E, Vergote I, Mathijssen RH, Berns EM, Verweij J, Pothof J, Wiemer EA (2013) miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene 32(36): 4284-4293
48. Wang Y, Mao H, Hao Q, Wang Y, Yang Y, Shen L, Huang S, Liu P (2012) Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer. Regul Pept 178(1-3): 36-42
49. Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, Zhan R, He X (2010) Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 30 untranslated region. Oncogene 29(15): 2302-2308
50. Xie Y, Tobin LA, Camps J, Wangsa D, Yang J, Rao M, Witasp E, Awad KS, Yoo N, Ried T, Kwong KF (2013) MicroRNA-24 regulates XIAP to reduce the apoptosis threshold in cancer cells. Oncogene 32(19): 2442-2451
51. Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K, Xu H, Jiang S (2013) miR-24-3p and miR-27a-3p promote cell proliferation in glioma cells via cooperative regulation of MXI1. Int J Oncol 42(2): 757-766
52. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ (2008) MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 68(2): 425-433
53. Zhang P, Li C, Zhang R, Zhang W, Jin C, Wang L, Song L (2015) The roles of two miRNAs in regulating the immune response of sea cucumber. Genetics 201(4): 1397-1410
54. Zheng T, Wang J, Chen X, Liu L (2010) Role of microRNA in anticancer drug resistance. Int J Cancer 126(1): 2-10
55. Zhou J, Wang W, Gao Z, Peng X, Chen X, Chen W, Xu W, Xu H, Lin MC, Jiang S (2013a) MicroRNA-155 promotes glioma cell proliferation via the regulation of MXI1. PloS one 8(12): e83055
56. Zhou P, Xu W, Peng X, Luo Z, Xing Q, Chen X, Hou C, Liang W, Zhou J, Wu X, Songyang Z, Jiang S (2013b) Large-scale screens of miRNA-mRNA interactions unveiled that the 30UTR of a gene is targeted by multiple miRNAs. PLoS One 8(7): e68204
57. Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J, Jiang B, Shu Y, Liu P (2012) miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother Pharmacol 69(3): 723-731